- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Astrocytoma or oligodendroglioma
- Meeting Date: July 2025
- Public Summary Document (PSD) July 2025 PBAC Meeting - (PDF)
- Public Summary Document (PSD) July 2025 PBAC Meeting - (Word)
Vorasidenib – July 2025
Vorasidenib; Tablet 10 mg, Tablet 40 mg; Voranigo®
Last updated
9 July 2025